| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING | 700 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 1000 ACADIA PHARMACEUTICALS | 13,405 | 24,990 |
| 500 WELLS FARGO & CO NEW | 19,985 | 22,700 |
| 1000 XERIUM TECHNOLOGIES NEW | 9,853 | 16,490 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| NH ANNUAL REPORT | 75 | 0 | 0 | |
| BANK CHARGES | 86 | 0 | 0 | |
| INVESTMENT INTEREST EXPENSE | 134 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| ICAHN ENTERPRISES LP | -20 | -20 | -20 |
| ICAHN ENTERPRISES LP | 30 | 30 | 30 |
| Description | Amount |
|---|---|
| TO ADJUST TO ACTUAL | 4,483 |